Human Immune Health Supplement Comprehensive Study by Type (Vitamin C, Vitamin D, Zinc, Selenium, Iron, Protein, Others), Application (Hospital, Clinic, Household, Others), Distribution Channel (Online, Offline, Pharma, Supermarket, Others), End User (Male, Female, Others) Players and Region - Global Market Outlook to 2027

Human Immune Health Supplement Market by XX Submarkets | Forecast Years 2022-2027  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Human Immune Health Supplement
Human Immune Health Supplements is one of the types of supplements which build the human immune system. The human immune health supplement which includes the many vitamins and supplement of proteins and essentials nitrous mineral for human health. Human immune health supplement refers to provide human immune to fight the Many deceases. The human immune health supplement includes the fresh vegies, cereal meat and many other things which build the human immune system. Vitamin C. Vitamin C may help prevent infections or shorten their stay. Vitamin E. Like vitamin C, vitamin E can be a powerful antioxidant that helps your body fight off infection. Vitamin A. Vitamin D. this type of supplement boosts the human immune health system.

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)


The global market is highly competitive, with a limited number of providers competing against one another. Concentrated competition, shifting consumer spending patterns, and frequent changes in consumer needs and desires create notable opportunities for market growth and business expansion. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Human Immune Health Supplement market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Nutramax Laboratories (United States), Cellderm Technologies Inc. (United States), Alticor Inc. (United States), EuroPharma Inc. (United States), Bayer AG (Germany), Koninklijke DSM N.V. (Netherlands), Kerry Group (Ireland), Vital Nutrients (Middletown), NutriGold Inc. (United States) and NOW Foods (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Seroyal International Inc (United States), Danisco A/S (Denmark) and Bio-Tech Pharmacal Inc (United States).

Segmentation Overview
AMA Research has segmented the market of Global Human Immune Health Supplement market by Type (Vitamin C, vitamin D, zinc, selenium, iron, protein and Others), Application (Hospital, Clinic, Household and Others) and Region.



On the basis of geography, the market of Human Immune Health Supplement has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Distribution Channel, the sub-segment i.e. Online will boost the Human Immune Health Supplement market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Male will boost the Human Immune Health Supplement market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Leaders and their expansionary development strategies
In 2021 PanTheryx Inc. Acquires TruBiotics Brand from Bayer HealthCare LLC. Due to this Acquisition PanTheryx expand their Digestive and Immune Health Product Lines for Human Nutrition.
On 4 may 2022 The Pura Collagen Launches New Immune Support System. The pura collagen has introduce a new supplement in global market which has aim to provide immune support for consumers. Its aim to build the immune system which help consumer to enhance to resist diseases.
The food safety and standard regulate the immune health supplement product under section 22 act. When a nutrient content claim is made on food products classified as health supplements, the individual nutrient content cannot be less than 15% of the recommended daily allowance.

Market Drivers
  • Growing Number of Various Diseases
  • Growing Demand in Older People

Opportunities
  • Growing Health Companion
  • Rising Demand of Nutrition in Urban Areas

Restraints
  • Lack Of Awareness About the Human Immune Health Supplement
  • Low Knowledge of Consumer About Human Immune Health Supplement

Challenges
  • Lack Of Information About Nutritional Diet
  • Side Effect Causing Due to Heavy Use


Key Target Audience
Human Immune Health Supplements Manufacturer, Vendor and Supplier, Government, Human Immune Health Supplements provider and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Report Objectives / Segmentation Covered

By Type
  • Vitamin C
  • vitamin D
  • zinc
  • selenium
  • iron
  • protein
  • Others
By Application
  • Hospital
  • Clinic
  • Household
  • Others
By Distribution Channel
  • Online
  • Offline
  • Pharma
  • Supermarket
  • Others

By End User
  • Male
  • Female
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Number of Various Diseases
      • 3.2.2. Growing Demand in Older People
    • 3.3. Market Challenges
      • 3.3.1. Lack Of Information About Nutritional Diet
      • 3.3.2. Side Effect Causing Due to Heavy Use
    • 3.4. Market Trends
      • 3.4.1. COVID-19 Has Left Strong Foot Print About Health and Wellness.
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Human Immune Health Supplement, by Type, Application, Distribution Channel, End User and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Human Immune Health Supplement (Value)
      • 5.2.1. Global Human Immune Health Supplement by: Type (Value)
        • 5.2.1.1. Vitamin C
        • 5.2.1.2. Vitamin D
        • 5.2.1.3. Zinc
        • 5.2.1.4. Selenium
        • 5.2.1.5. Iron
        • 5.2.1.6. Protein
        • 5.2.1.7. Others
      • 5.2.2. Global Human Immune Health Supplement by: Application (Value)
        • 5.2.2.1. Hospital
        • 5.2.2.2. Clinic
        • 5.2.2.3. Household
        • 5.2.2.4. Others
      • 5.2.3. Global Human Immune Health Supplement by: Distribution Channel (Value)
        • 5.2.3.1. Online
        • 5.2.3.2. Offline
        • 5.2.3.3. Pharma
        • 5.2.3.4. Supermarket
        • 5.2.3.5. Others
      • 5.2.4. Global Human Immune Health Supplement by: End User (Value)
        • 5.2.4.1. Male
        • 5.2.4.2. Female
        • 5.2.4.3. Others
      • 5.2.5. Global Human Immune Health Supplement Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Human Immune Health Supplement (Price)
      • 5.3.1. Global Human Immune Health Supplement by: Type (Price)
  • 6. Human Immune Health Supplement: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Nutramax Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Cellderm Technologies Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Alticor Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. EuroPharma Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Bayer AG (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Koninklijke DSM N.V. (Netherlands)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Kerry Group (Ireland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Vital Nutrients (Middletown)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. NutriGold Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. NOW Foods (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Human Immune Health Supplement Sale, by Type, Application, Distribution Channel, End User and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Human Immune Health Supplement (Value)
      • 7.2.1. Global Human Immune Health Supplement by: Type (Value)
        • 7.2.1.1. Vitamin C
        • 7.2.1.2. Vitamin D
        • 7.2.1.3. Zinc
        • 7.2.1.4. Selenium
        • 7.2.1.5. Iron
        • 7.2.1.6. Protein
        • 7.2.1.7. Others
      • 7.2.2. Global Human Immune Health Supplement by: Application (Value)
        • 7.2.2.1. Hospital
        • 7.2.2.2. Clinic
        • 7.2.2.3. Household
        • 7.2.2.4. Others
      • 7.2.3. Global Human Immune Health Supplement by: Distribution Channel (Value)
        • 7.2.3.1. Online
        • 7.2.3.2. Offline
        • 7.2.3.3. Pharma
        • 7.2.3.4. Supermarket
        • 7.2.3.5. Others
      • 7.2.4. Global Human Immune Health Supplement by: End User (Value)
        • 7.2.4.1. Male
        • 7.2.4.2. Female
        • 7.2.4.3. Others
      • 7.2.5. Global Human Immune Health Supplement Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Human Immune Health Supplement (Price)
      • 7.3.1. Global Human Immune Health Supplement by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Human Immune Health Supplement: by Type(USD Million)
  • Table 2. Human Immune Health Supplement Vitamin C , by Region USD Million (2016-2021)
  • Table 3. Human Immune Health Supplement Vitamin D , by Region USD Million (2016-2021)
  • Table 4. Human Immune Health Supplement Zinc , by Region USD Million (2016-2021)
  • Table 5. Human Immune Health Supplement Selenium , by Region USD Million (2016-2021)
  • Table 6. Human Immune Health Supplement Iron , by Region USD Million (2016-2021)
  • Table 7. Human Immune Health Supplement Protein , by Region USD Million (2016-2021)
  • Table 8. Human Immune Health Supplement Others , by Region USD Million (2016-2021)
  • Table 9. Human Immune Health Supplement: by Application(USD Million)
  • Table 10. Human Immune Health Supplement Hospital , by Region USD Million (2016-2021)
  • Table 11. Human Immune Health Supplement Clinic , by Region USD Million (2016-2021)
  • Table 12. Human Immune Health Supplement Household , by Region USD Million (2016-2021)
  • Table 13. Human Immune Health Supplement Others , by Region USD Million (2016-2021)
  • Table 14. Human Immune Health Supplement: by Distribution Channel(USD Million)
  • Table 15. Human Immune Health Supplement Online , by Region USD Million (2016-2021)
  • Table 16. Human Immune Health Supplement Offline , by Region USD Million (2016-2021)
  • Table 17. Human Immune Health Supplement Pharma , by Region USD Million (2016-2021)
  • Table 18. Human Immune Health Supplement Supermarket , by Region USD Million (2016-2021)
  • Table 19. Human Immune Health Supplement Others , by Region USD Million (2016-2021)
  • Table 20. Human Immune Health Supplement: by End User(USD Million)
  • Table 21. Human Immune Health Supplement Male , by Region USD Million (2016-2021)
  • Table 22. Human Immune Health Supplement Female , by Region USD Million (2016-2021)
  • Table 23. Human Immune Health Supplement Others , by Region USD Million (2016-2021)
  • Table 24. South America Human Immune Health Supplement, by Country USD Million (2016-2021)
  • Table 25. South America Human Immune Health Supplement, by Type USD Million (2016-2021)
  • Table 26. South America Human Immune Health Supplement, by Application USD Million (2016-2021)
  • Table 27. South America Human Immune Health Supplement, by Distribution Channel USD Million (2016-2021)
  • Table 28. South America Human Immune Health Supplement, by End User USD Million (2016-2021)
  • Table 29. Brazil Human Immune Health Supplement, by Type USD Million (2016-2021)
  • Table 30. Brazil Human Immune Health Supplement, by Application USD Million (2016-2021)
  • Table 31. Brazil Human Immune Health Supplement, by Distribution Channel USD Million (2016-2021)
  • Table 32. Brazil Human Immune Health Supplement, by End User USD Million (2016-2021)
  • Table 33. Argentina Human Immune Health Supplement, by Type USD Million (2016-2021)
  • Table 34. Argentina Human Immune Health Supplement, by Application USD Million (2016-2021)
  • Table 35. Argentina Human Immune Health Supplement, by Distribution Channel USD Million (2016-2021)
  • Table 36. Argentina Human Immune Health Supplement, by End User USD Million (2016-2021)
  • Table 37. Rest of South America Human Immune Health Supplement, by Type USD Million (2016-2021)
  • Table 38. Rest of South America Human Immune Health Supplement, by Application USD Million (2016-2021)
  • Table 39. Rest of South America Human Immune Health Supplement, by Distribution Channel USD Million (2016-2021)
  • Table 40. Rest of South America Human Immune Health Supplement, by End User USD Million (2016-2021)
  • Table 41. Asia Pacific Human Immune Health Supplement, by Country USD Million (2016-2021)
  • Table 42. Asia Pacific Human Immune Health Supplement, by Type USD Million (2016-2021)
  • Table 43. Asia Pacific Human Immune Health Supplement, by Application USD Million (2016-2021)
  • Table 44. Asia Pacific Human Immune Health Supplement, by Distribution Channel USD Million (2016-2021)
  • Table 45. Asia Pacific Human Immune Health Supplement, by End User USD Million (2016-2021)
  • Table 46. China Human Immune Health Supplement, by Type USD Million (2016-2021)
  • Table 47. China Human Immune Health Supplement, by Application USD Million (2016-2021)
  • Table 48. China Human Immune Health Supplement, by Distribution Channel USD Million (2016-2021)
  • Table 49. China Human Immune Health Supplement, by End User USD Million (2016-2021)
  • Table 50. Japan Human Immune Health Supplement, by Type USD Million (2016-2021)
  • Table 51. Japan Human Immune Health Supplement, by Application USD Million (2016-2021)
  • Table 52. Japan Human Immune Health Supplement, by Distribution Channel USD Million (2016-2021)
  • Table 53. Japan Human Immune Health Supplement, by End User USD Million (2016-2021)
  • Table 54. India Human Immune Health Supplement, by Type USD Million (2016-2021)
  • Table 55. India Human Immune Health Supplement, by Application USD Million (2016-2021)
  • Table 56. India Human Immune Health Supplement, by Distribution Channel USD Million (2016-2021)
  • Table 57. India Human Immune Health Supplement, by End User USD Million (2016-2021)
  • Table 58. South Korea Human Immune Health Supplement, by Type USD Million (2016-2021)
  • Table 59. South Korea Human Immune Health Supplement, by Application USD Million (2016-2021)
  • Table 60. South Korea Human Immune Health Supplement, by Distribution Channel USD Million (2016-2021)
  • Table 61. South Korea Human Immune Health Supplement, by End User USD Million (2016-2021)
  • Table 62. Taiwan Human Immune Health Supplement, by Type USD Million (2016-2021)
  • Table 63. Taiwan Human Immune Health Supplement, by Application USD Million (2016-2021)
  • Table 64. Taiwan Human Immune Health Supplement, by Distribution Channel USD Million (2016-2021)
  • Table 65. Taiwan Human Immune Health Supplement, by End User USD Million (2016-2021)
  • Table 66. Australia Human Immune Health Supplement, by Type USD Million (2016-2021)
  • Table 67. Australia Human Immune Health Supplement, by Application USD Million (2016-2021)
  • Table 68. Australia Human Immune Health Supplement, by Distribution Channel USD Million (2016-2021)
  • Table 69. Australia Human Immune Health Supplement, by End User USD Million (2016-2021)
  • Table 70. Rest of Asia-Pacific Human Immune Health Supplement, by Type USD Million (2016-2021)
  • Table 71. Rest of Asia-Pacific Human Immune Health Supplement, by Application USD Million (2016-2021)
  • Table 72. Rest of Asia-Pacific Human Immune Health Supplement, by Distribution Channel USD Million (2016-2021)
  • Table 73. Rest of Asia-Pacific Human Immune Health Supplement, by End User USD Million (2016-2021)
  • Table 74. Europe Human Immune Health Supplement, by Country USD Million (2016-2021)
  • Table 75. Europe Human Immune Health Supplement, by Type USD Million (2016-2021)
  • Table 76. Europe Human Immune Health Supplement, by Application USD Million (2016-2021)
  • Table 77. Europe Human Immune Health Supplement, by Distribution Channel USD Million (2016-2021)
  • Table 78. Europe Human Immune Health Supplement, by End User USD Million (2016-2021)
  • Table 79. Germany Human Immune Health Supplement, by Type USD Million (2016-2021)
  • Table 80. Germany Human Immune Health Supplement, by Application USD Million (2016-2021)
  • Table 81. Germany Human Immune Health Supplement, by Distribution Channel USD Million (2016-2021)
  • Table 82. Germany Human Immune Health Supplement, by End User USD Million (2016-2021)
  • Table 83. France Human Immune Health Supplement, by Type USD Million (2016-2021)
  • Table 84. France Human Immune Health Supplement, by Application USD Million (2016-2021)
  • Table 85. France Human Immune Health Supplement, by Distribution Channel USD Million (2016-2021)
  • Table 86. France Human Immune Health Supplement, by End User USD Million (2016-2021)
  • Table 87. Italy Human Immune Health Supplement, by Type USD Million (2016-2021)
  • Table 88. Italy Human Immune Health Supplement, by Application USD Million (2016-2021)
  • Table 89. Italy Human Immune Health Supplement, by Distribution Channel USD Million (2016-2021)
  • Table 90. Italy Human Immune Health Supplement, by End User USD Million (2016-2021)
  • Table 91. United Kingdom Human Immune Health Supplement, by Type USD Million (2016-2021)
  • Table 92. United Kingdom Human Immune Health Supplement, by Application USD Million (2016-2021)
  • Table 93. United Kingdom Human Immune Health Supplement, by Distribution Channel USD Million (2016-2021)
  • Table 94. United Kingdom Human Immune Health Supplement, by End User USD Million (2016-2021)
  • Table 95. Netherlands Human Immune Health Supplement, by Type USD Million (2016-2021)
  • Table 96. Netherlands Human Immune Health Supplement, by Application USD Million (2016-2021)
  • Table 97. Netherlands Human Immune Health Supplement, by Distribution Channel USD Million (2016-2021)
  • Table 98. Netherlands Human Immune Health Supplement, by End User USD Million (2016-2021)
  • Table 99. Rest of Europe Human Immune Health Supplement, by Type USD Million (2016-2021)
  • Table 100. Rest of Europe Human Immune Health Supplement, by Application USD Million (2016-2021)
  • Table 101. Rest of Europe Human Immune Health Supplement, by Distribution Channel USD Million (2016-2021)
  • Table 102. Rest of Europe Human Immune Health Supplement, by End User USD Million (2016-2021)
  • Table 103. MEA Human Immune Health Supplement, by Country USD Million (2016-2021)
  • Table 104. MEA Human Immune Health Supplement, by Type USD Million (2016-2021)
  • Table 105. MEA Human Immune Health Supplement, by Application USD Million (2016-2021)
  • Table 106. MEA Human Immune Health Supplement, by Distribution Channel USD Million (2016-2021)
  • Table 107. MEA Human Immune Health Supplement, by End User USD Million (2016-2021)
  • Table 108. Middle East Human Immune Health Supplement, by Type USD Million (2016-2021)
  • Table 109. Middle East Human Immune Health Supplement, by Application USD Million (2016-2021)
  • Table 110. Middle East Human Immune Health Supplement, by Distribution Channel USD Million (2016-2021)
  • Table 111. Middle East Human Immune Health Supplement, by End User USD Million (2016-2021)
  • Table 112. Africa Human Immune Health Supplement, by Type USD Million (2016-2021)
  • Table 113. Africa Human Immune Health Supplement, by Application USD Million (2016-2021)
  • Table 114. Africa Human Immune Health Supplement, by Distribution Channel USD Million (2016-2021)
  • Table 115. Africa Human Immune Health Supplement, by End User USD Million (2016-2021)
  • Table 116. North America Human Immune Health Supplement, by Country USD Million (2016-2021)
  • Table 117. North America Human Immune Health Supplement, by Type USD Million (2016-2021)
  • Table 118. North America Human Immune Health Supplement, by Application USD Million (2016-2021)
  • Table 119. North America Human Immune Health Supplement, by Distribution Channel USD Million (2016-2021)
  • Table 120. North America Human Immune Health Supplement, by End User USD Million (2016-2021)
  • Table 121. United States Human Immune Health Supplement, by Type USD Million (2016-2021)
  • Table 122. United States Human Immune Health Supplement, by Application USD Million (2016-2021)
  • Table 123. United States Human Immune Health Supplement, by Distribution Channel USD Million (2016-2021)
  • Table 124. United States Human Immune Health Supplement, by End User USD Million (2016-2021)
  • Table 125. Canada Human Immune Health Supplement, by Type USD Million (2016-2021)
  • Table 126. Canada Human Immune Health Supplement, by Application USD Million (2016-2021)
  • Table 127. Canada Human Immune Health Supplement, by Distribution Channel USD Million (2016-2021)
  • Table 128. Canada Human Immune Health Supplement, by End User USD Million (2016-2021)
  • Table 129. Mexico Human Immune Health Supplement, by Type USD Million (2016-2021)
  • Table 130. Mexico Human Immune Health Supplement, by Application USD Million (2016-2021)
  • Table 131. Mexico Human Immune Health Supplement, by Distribution Channel USD Million (2016-2021)
  • Table 132. Mexico Human Immune Health Supplement, by End User USD Million (2016-2021)
  • Table 133. Human Immune Health Supplement: by Type(USD/Units)
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Human Immune Health Supplement: by Type(USD Million)
  • Table 145. Human Immune Health Supplement Vitamin C , by Region USD Million (2022-2027)
  • Table 146. Human Immune Health Supplement Vitamin D , by Region USD Million (2022-2027)
  • Table 147. Human Immune Health Supplement Zinc , by Region USD Million (2022-2027)
  • Table 148. Human Immune Health Supplement Selenium , by Region USD Million (2022-2027)
  • Table 149. Human Immune Health Supplement Iron , by Region USD Million (2022-2027)
  • Table 150. Human Immune Health Supplement Protein , by Region USD Million (2022-2027)
  • Table 151. Human Immune Health Supplement Others , by Region USD Million (2022-2027)
  • Table 152. Human Immune Health Supplement: by Application(USD Million)
  • Table 153. Human Immune Health Supplement Hospital , by Region USD Million (2022-2027)
  • Table 154. Human Immune Health Supplement Clinic , by Region USD Million (2022-2027)
  • Table 155. Human Immune Health Supplement Household , by Region USD Million (2022-2027)
  • Table 156. Human Immune Health Supplement Others , by Region USD Million (2022-2027)
  • Table 157. Human Immune Health Supplement: by Distribution Channel(USD Million)
  • Table 158. Human Immune Health Supplement Online , by Region USD Million (2022-2027)
  • Table 159. Human Immune Health Supplement Offline , by Region USD Million (2022-2027)
  • Table 160. Human Immune Health Supplement Pharma , by Region USD Million (2022-2027)
  • Table 161. Human Immune Health Supplement Supermarket , by Region USD Million (2022-2027)
  • Table 162. Human Immune Health Supplement Others , by Region USD Million (2022-2027)
  • Table 163. Human Immune Health Supplement: by End User(USD Million)
  • Table 164. Human Immune Health Supplement Male , by Region USD Million (2022-2027)
  • Table 165. Human Immune Health Supplement Female , by Region USD Million (2022-2027)
  • Table 166. Human Immune Health Supplement Others , by Region USD Million (2022-2027)
  • Table 167. South America Human Immune Health Supplement, by Country USD Million (2022-2027)
  • Table 168. South America Human Immune Health Supplement, by Type USD Million (2022-2027)
  • Table 169. South America Human Immune Health Supplement, by Application USD Million (2022-2027)
  • Table 170. South America Human Immune Health Supplement, by Distribution Channel USD Million (2022-2027)
  • Table 171. South America Human Immune Health Supplement, by End User USD Million (2022-2027)
  • Table 172. Brazil Human Immune Health Supplement, by Type USD Million (2022-2027)
  • Table 173. Brazil Human Immune Health Supplement, by Application USD Million (2022-2027)
  • Table 174. Brazil Human Immune Health Supplement, by Distribution Channel USD Million (2022-2027)
  • Table 175. Brazil Human Immune Health Supplement, by End User USD Million (2022-2027)
  • Table 176. Argentina Human Immune Health Supplement, by Type USD Million (2022-2027)
  • Table 177. Argentina Human Immune Health Supplement, by Application USD Million (2022-2027)
  • Table 178. Argentina Human Immune Health Supplement, by Distribution Channel USD Million (2022-2027)
  • Table 179. Argentina Human Immune Health Supplement, by End User USD Million (2022-2027)
  • Table 180. Rest of South America Human Immune Health Supplement, by Type USD Million (2022-2027)
  • Table 181. Rest of South America Human Immune Health Supplement, by Application USD Million (2022-2027)
  • Table 182. Rest of South America Human Immune Health Supplement, by Distribution Channel USD Million (2022-2027)
  • Table 183. Rest of South America Human Immune Health Supplement, by End User USD Million (2022-2027)
  • Table 184. Asia Pacific Human Immune Health Supplement, by Country USD Million (2022-2027)
  • Table 185. Asia Pacific Human Immune Health Supplement, by Type USD Million (2022-2027)
  • Table 186. Asia Pacific Human Immune Health Supplement, by Application USD Million (2022-2027)
  • Table 187. Asia Pacific Human Immune Health Supplement, by Distribution Channel USD Million (2022-2027)
  • Table 188. Asia Pacific Human Immune Health Supplement, by End User USD Million (2022-2027)
  • Table 189. China Human Immune Health Supplement, by Type USD Million (2022-2027)
  • Table 190. China Human Immune Health Supplement, by Application USD Million (2022-2027)
  • Table 191. China Human Immune Health Supplement, by Distribution Channel USD Million (2022-2027)
  • Table 192. China Human Immune Health Supplement, by End User USD Million (2022-2027)
  • Table 193. Japan Human Immune Health Supplement, by Type USD Million (2022-2027)
  • Table 194. Japan Human Immune Health Supplement, by Application USD Million (2022-2027)
  • Table 195. Japan Human Immune Health Supplement, by Distribution Channel USD Million (2022-2027)
  • Table 196. Japan Human Immune Health Supplement, by End User USD Million (2022-2027)
  • Table 197. India Human Immune Health Supplement, by Type USD Million (2022-2027)
  • Table 198. India Human Immune Health Supplement, by Application USD Million (2022-2027)
  • Table 199. India Human Immune Health Supplement, by Distribution Channel USD Million (2022-2027)
  • Table 200. India Human Immune Health Supplement, by End User USD Million (2022-2027)
  • Table 201. South Korea Human Immune Health Supplement, by Type USD Million (2022-2027)
  • Table 202. South Korea Human Immune Health Supplement, by Application USD Million (2022-2027)
  • Table 203. South Korea Human Immune Health Supplement, by Distribution Channel USD Million (2022-2027)
  • Table 204. South Korea Human Immune Health Supplement, by End User USD Million (2022-2027)
  • Table 205. Taiwan Human Immune Health Supplement, by Type USD Million (2022-2027)
  • Table 206. Taiwan Human Immune Health Supplement, by Application USD Million (2022-2027)
  • Table 207. Taiwan Human Immune Health Supplement, by Distribution Channel USD Million (2022-2027)
  • Table 208. Taiwan Human Immune Health Supplement, by End User USD Million (2022-2027)
  • Table 209. Australia Human Immune Health Supplement, by Type USD Million (2022-2027)
  • Table 210. Australia Human Immune Health Supplement, by Application USD Million (2022-2027)
  • Table 211. Australia Human Immune Health Supplement, by Distribution Channel USD Million (2022-2027)
  • Table 212. Australia Human Immune Health Supplement, by End User USD Million (2022-2027)
  • Table 213. Rest of Asia-Pacific Human Immune Health Supplement, by Type USD Million (2022-2027)
  • Table 214. Rest of Asia-Pacific Human Immune Health Supplement, by Application USD Million (2022-2027)
  • Table 215. Rest of Asia-Pacific Human Immune Health Supplement, by Distribution Channel USD Million (2022-2027)
  • Table 216. Rest of Asia-Pacific Human Immune Health Supplement, by End User USD Million (2022-2027)
  • Table 217. Europe Human Immune Health Supplement, by Country USD Million (2022-2027)
  • Table 218. Europe Human Immune Health Supplement, by Type USD Million (2022-2027)
  • Table 219. Europe Human Immune Health Supplement, by Application USD Million (2022-2027)
  • Table 220. Europe Human Immune Health Supplement, by Distribution Channel USD Million (2022-2027)
  • Table 221. Europe Human Immune Health Supplement, by End User USD Million (2022-2027)
  • Table 222. Germany Human Immune Health Supplement, by Type USD Million (2022-2027)
  • Table 223. Germany Human Immune Health Supplement, by Application USD Million (2022-2027)
  • Table 224. Germany Human Immune Health Supplement, by Distribution Channel USD Million (2022-2027)
  • Table 225. Germany Human Immune Health Supplement, by End User USD Million (2022-2027)
  • Table 226. France Human Immune Health Supplement, by Type USD Million (2022-2027)
  • Table 227. France Human Immune Health Supplement, by Application USD Million (2022-2027)
  • Table 228. France Human Immune Health Supplement, by Distribution Channel USD Million (2022-2027)
  • Table 229. France Human Immune Health Supplement, by End User USD Million (2022-2027)
  • Table 230. Italy Human Immune Health Supplement, by Type USD Million (2022-2027)
  • Table 231. Italy Human Immune Health Supplement, by Application USD Million (2022-2027)
  • Table 232. Italy Human Immune Health Supplement, by Distribution Channel USD Million (2022-2027)
  • Table 233. Italy Human Immune Health Supplement, by End User USD Million (2022-2027)
  • Table 234. United Kingdom Human Immune Health Supplement, by Type USD Million (2022-2027)
  • Table 235. United Kingdom Human Immune Health Supplement, by Application USD Million (2022-2027)
  • Table 236. United Kingdom Human Immune Health Supplement, by Distribution Channel USD Million (2022-2027)
  • Table 237. United Kingdom Human Immune Health Supplement, by End User USD Million (2022-2027)
  • Table 238. Netherlands Human Immune Health Supplement, by Type USD Million (2022-2027)
  • Table 239. Netherlands Human Immune Health Supplement, by Application USD Million (2022-2027)
  • Table 240. Netherlands Human Immune Health Supplement, by Distribution Channel USD Million (2022-2027)
  • Table 241. Netherlands Human Immune Health Supplement, by End User USD Million (2022-2027)
  • Table 242. Rest of Europe Human Immune Health Supplement, by Type USD Million (2022-2027)
  • Table 243. Rest of Europe Human Immune Health Supplement, by Application USD Million (2022-2027)
  • Table 244. Rest of Europe Human Immune Health Supplement, by Distribution Channel USD Million (2022-2027)
  • Table 245. Rest of Europe Human Immune Health Supplement, by End User USD Million (2022-2027)
  • Table 246. MEA Human Immune Health Supplement, by Country USD Million (2022-2027)
  • Table 247. MEA Human Immune Health Supplement, by Type USD Million (2022-2027)
  • Table 248. MEA Human Immune Health Supplement, by Application USD Million (2022-2027)
  • Table 249. MEA Human Immune Health Supplement, by Distribution Channel USD Million (2022-2027)
  • Table 250. MEA Human Immune Health Supplement, by End User USD Million (2022-2027)
  • Table 251. Middle East Human Immune Health Supplement, by Type USD Million (2022-2027)
  • Table 252. Middle East Human Immune Health Supplement, by Application USD Million (2022-2027)
  • Table 253. Middle East Human Immune Health Supplement, by Distribution Channel USD Million (2022-2027)
  • Table 254. Middle East Human Immune Health Supplement, by End User USD Million (2022-2027)
  • Table 255. Africa Human Immune Health Supplement, by Type USD Million (2022-2027)
  • Table 256. Africa Human Immune Health Supplement, by Application USD Million (2022-2027)
  • Table 257. Africa Human Immune Health Supplement, by Distribution Channel USD Million (2022-2027)
  • Table 258. Africa Human Immune Health Supplement, by End User USD Million (2022-2027)
  • Table 259. North America Human Immune Health Supplement, by Country USD Million (2022-2027)
  • Table 260. North America Human Immune Health Supplement, by Type USD Million (2022-2027)
  • Table 261. North America Human Immune Health Supplement, by Application USD Million (2022-2027)
  • Table 262. North America Human Immune Health Supplement, by Distribution Channel USD Million (2022-2027)
  • Table 263. North America Human Immune Health Supplement, by End User USD Million (2022-2027)
  • Table 264. United States Human Immune Health Supplement, by Type USD Million (2022-2027)
  • Table 265. United States Human Immune Health Supplement, by Application USD Million (2022-2027)
  • Table 266. United States Human Immune Health Supplement, by Distribution Channel USD Million (2022-2027)
  • Table 267. United States Human Immune Health Supplement, by End User USD Million (2022-2027)
  • Table 268. Canada Human Immune Health Supplement, by Type USD Million (2022-2027)
  • Table 269. Canada Human Immune Health Supplement, by Application USD Million (2022-2027)
  • Table 270. Canada Human Immune Health Supplement, by Distribution Channel USD Million (2022-2027)
  • Table 271. Canada Human Immune Health Supplement, by End User USD Million (2022-2027)
  • Table 272. Mexico Human Immune Health Supplement, by Type USD Million (2022-2027)
  • Table 273. Mexico Human Immune Health Supplement, by Application USD Million (2022-2027)
  • Table 274. Mexico Human Immune Health Supplement, by Distribution Channel USD Million (2022-2027)
  • Table 275. Mexico Human Immune Health Supplement, by End User USD Million (2022-2027)
  • Table 276. Human Immune Health Supplement: by Type(USD/Units)
  • Table 277. Research Programs/Design for This Report
  • Table 278. Key Data Information from Secondary Sources
  • Table 279. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Human Immune Health Supplement: by Type USD Million (2016-2021)
  • Figure 5. Global Human Immune Health Supplement: by Application USD Million (2016-2021)
  • Figure 6. Global Human Immune Health Supplement: by Distribution Channel USD Million (2016-2021)
  • Figure 7. Global Human Immune Health Supplement: by End User USD Million (2016-2021)
  • Figure 8. South America Human Immune Health Supplement Share (%), by Country
  • Figure 9. Asia Pacific Human Immune Health Supplement Share (%), by Country
  • Figure 10. Europe Human Immune Health Supplement Share (%), by Country
  • Figure 11. MEA Human Immune Health Supplement Share (%), by Country
  • Figure 12. North America Human Immune Health Supplement Share (%), by Country
  • Figure 13. Global Human Immune Health Supplement: by Type USD/Units (2016-2021)
  • Figure 14. Global Human Immune Health Supplement share by Players 2021 (%)
  • Figure 15. Global Human Immune Health Supplement share by Players (Top 3) 2021(%)
  • Figure 16. Global Human Immune Health Supplement share by Players (Top 5) 2021(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Nutramax Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 19. Nutramax Laboratories (United States) Revenue: by Geography 2021
  • Figure 20. Cellderm Technologies Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Cellderm Technologies Inc. (United States) Revenue: by Geography 2021
  • Figure 22. Alticor Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. Alticor Inc. (United States) Revenue: by Geography 2021
  • Figure 24. EuroPharma Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 25. EuroPharma Inc. (United States) Revenue: by Geography 2021
  • Figure 26. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 27. Bayer AG (Germany) Revenue: by Geography 2021
  • Figure 28. Koninklijke DSM N.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 29. Koninklijke DSM N.V. (Netherlands) Revenue: by Geography 2021
  • Figure 30. Kerry Group (Ireland) Revenue, Net Income and Gross profit
  • Figure 31. Kerry Group (Ireland) Revenue: by Geography 2021
  • Figure 32. Vital Nutrients (Middletown) Revenue, Net Income and Gross profit
  • Figure 33. Vital Nutrients (Middletown) Revenue: by Geography 2021
  • Figure 34. NutriGold Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 35. NutriGold Inc. (United States) Revenue: by Geography 2021
  • Figure 36. NOW Foods (United States) Revenue, Net Income and Gross profit
  • Figure 37. NOW Foods (United States) Revenue: by Geography 2021
  • Figure 38. Global Human Immune Health Supplement: by Type USD Million (2022-2027)
  • Figure 39. Global Human Immune Health Supplement: by Application USD Million (2022-2027)
  • Figure 40. Global Human Immune Health Supplement: by Distribution Channel USD Million (2022-2027)
  • Figure 41. Global Human Immune Health Supplement: by End User USD Million (2022-2027)
  • Figure 42. South America Human Immune Health Supplement Share (%), by Country
  • Figure 43. Asia Pacific Human Immune Health Supplement Share (%), by Country
  • Figure 44. Europe Human Immune Health Supplement Share (%), by Country
  • Figure 45. MEA Human Immune Health Supplement Share (%), by Country
  • Figure 46. North America Human Immune Health Supplement Share (%), by Country
  • Figure 47. Global Human Immune Health Supplement: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • Nutramax Laboratories (United States)
  • Cellderm Technologies Inc. (United States)
  • Alticor Inc. (United States)
  • EuroPharma Inc. (United States)
  • Bayer AG (Germany)
  • Koninklijke DSM N.V. (Netherlands)
  • Kerry Group (Ireland)
  • Vital Nutrients (Middletown)
  • NutriGold Inc. (United States)
  • NOW Foods (United States)
Additional players considered in the study are as follows:
Seroyal International Inc (United States) , Danisco A/S (Denmark) , Bio-Tech Pharmacal Inc (United States)
Select User Access Type

Key Highlights of Report


Jul 2022 244 Pages 88 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Nutramax Laboratories (United States), Cellderm Technologies Inc. (United States), Alticor Inc. (United States), EuroPharma Inc. (United States), Bayer AG (Germany), Koninklijke DSM N.V. (Netherlands), Kerry Group (Ireland), Vital Nutrients (Middletown), NutriGold Inc. (United States) and NOW Foods (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"COVID-19 Has Left Strong Foot Print About Health and Wellness." is seen as one of major influencing trends for Human Immune Health Supplement Market during projected period 2021-2027.
The Human Immune Health Supplement market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Human Immune Health Supplement Market Report?